Skip to main content
Clinical Trials/NCT02224222
NCT02224222
Unknown
N/A

Assessment of Frailty as a Risk Factor for Cardiac and Vascular Surgery

Semmelweis University Heart and Vascular Center1 site in 1 country300 target enrollmentJuly 2014

Overview

Phase
N/A
Intervention
Not specified
Conditions
Intellectual Frailty of Aging
Sponsor
Semmelweis University Heart and Vascular Center
Enrollment
300
Locations
1
Primary Endpoint
Length of hospital and intensive care unit stay.
Last Updated
7 years ago

Overview

Brief Summary

The purpose of this study is to assess the impact of frailty as a multidimensional risk factor on the outcomes of adult cardiac and vascular surgery. For the purpose of defining patient frailty a multimodal questionnaire has been developed including measurement of psychological, socioeconomical, neurological and behavioral aspects. This study also features an investigation of the possible relationship between sudden regional weather changes, individual meteorological susceptibility of the patients and the outcomes of adult cardiac and vascular surgery.

Registry
clinicaltrials.gov
Start Date
July 2014
End Date
July 2020
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Semmelweis University Heart and Vascular Center
Responsible Party
Principal Investigator
Principal Investigator

Andrea Szekely

Associate professor

Semmelweis University

Eligibility Criteria

Inclusion Criteria

  • Patients, 18 years or older, admitted to the hospital for elective cardiac or vascular surgery.

Exclusion Criteria

  • Not willing to participate.
  • Pregnant women.
  • During active psychiatric hospital care.
  • Patients with defined legal incapability or limited capability.
  • Congenital or acquired speech impediment and locomotion disability of any kind.
  • Non-evaluable patient due to communication problems and insufficient clinical information for the judgement of frailty (CFS).
  • Patients admitted solely for elective surgery of the varices of the lower extremities.
  • Patients with a transplanted heart.

Outcomes

Primary Outcomes

Length of hospital and intensive care unit stay.

Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 2 weeks.

Secondary Outcomes

  • The composite of in-hospital death from any cause.(Participants will be followed for the duration of hospital stay, an expected average of 2 weeks.)
  • Evidence of clinically definite postoperative acute kidney injury and the need for dialysis.(Participants will be followed for the duration of hospital stay, an expected average of 2 weeks.)
  • Evidence of clinically definite postoperative low cardiac output syndrome.(Participants will be followed for the duration of hospital stay, an expected average of 2 weeks.)
  • Evidence of clinically definite postoperative cardiac arrythmias.(Participants will be followed for the duration of hospital stay, an expected average of 2 weeks.)
  • Evidence of clinically definite postoperative SIRS.(Participants will be followed for the duration of hospital stay, an expected average of 2 weeks.)
  • Evidence of clinically definite postoperative acute lung injury and the need for mechanical ventilation.(Participants will be followed for the duration of hospital stay, an expected average of 2 weeks.)
  • Evidence of clinically definite postoperative peripheral vascular insufficiency.(Participants will be followed for the duration of hospital stay, an expected average of 2 weeks.)
  • The need for reoperation due to bleeding.(Participants will be followed for the duration of hospital stay, an expected average of 2 weeks.)

Study Sites (1)

Loading locations...

Similar Trials